In this virtual discussion, a panel of government speakers will address technical topics related to device technologies, stimulation modalities, and targeting approaches. Panelists will also discuss the Phase 1 submission form, judging criteria, and target performance considerations in greater technical detail.
A video recording of the session will be shared following the event.
More about the $9.8 million competition
The Neuromod Prize is a SPARC (Stimulating Peripheral Activity to Relieve Conditions) initiative from NIH that is accelerating the development of targeted neuromodulation therapies. The first phase calls on scientists, engineers, and clinicians to submit novel concepts and plans for development.
The competition is open to U.S. participants, subject to eligibility requirements. Phase 1 participants will submit concept papers describing their proposed therapeutic approaches, their plans for conducting proof-of-concept studies, their rationales for therapeutic use, and their expectations for clinical impact. Submissions are due by 4:59 p.m. EDT on April 28.
Explore the Neuromod Prize resource hub to learn more about present and emerging methods for bioelectronic medicine, research tools, clinical translation, and target performance considerations.
Receive all updates about the technical panel and other competition resources: Subscribe to the Neuromod Prize newsletter.